Winteam Sells Its 51% Ownership in Zhongtai Biological

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

August 27, 2013 -- Winteam Pharma will sell its 51% stake in Guizhou Zhongtai Biological Technology for 101 million RMB ($16.5 million), representing a small gain of $2.5 million. Zhongtai is a plasma-based biopharma with operations in mainland China. In May, Winteam boughtTongjitang Chinese Medicines, paying $393 million, making it seem likely that Winteam is raising cash and focusing its operations. More details....

Stock Symbol: (HK: 00570)

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC